Education History
| Fellowship |
Huntsman Cancer Institute, University of Utah Spencer Fox Eccles School of Medicine |
Fellow |
|---|---|---|
| Residency |
University of California, San Francisco School of Medicine |
Resident |
| Professional Medical |
University of Utah School of Medicine |
MD, PhD |
| Undergraduate |
Bowdoin College |
AB |
Selected Publications
Journal Article
- Scholz P, Thompson J, Crosby KT, Fauth T, Krah NM, Schlauderaff G, Back R, Berkheimer ZA, Jolley A, Sombroek D, Medert R, Zurek C, Dmytrenko O, Wilson E, Schut FT, Rutter J, Zhang X, Krohn M, Jackson RN, Beisel CL, Liu Y (2026). RNA-triggered cell killing with CRISPR-Cas12a2. Nature, 655(8121), 230-239.
- Zeng J, Cheng Z, Chen H, Wang Z, Thompson J, Crosby KT, Han H, Singhal A, Ngo W, Xia C, Rosas-Rivera D, Zhang Z, Kang MH, Mao Y, Diolaiti ME, Lee GC, Diffley JFX, Song Y, Qiu L, Krah NM, Murthy N, Jackson RN, Liu Y, Ashworth A, Doudna JA (2026). Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin Shredding. Nature.
- Ziehr DR, Li F, Parnell KM, Krah NM, Leahy KJ, Guillermier C, Gao C, Prell SA, Vigder N, Poli S, Varon J, Baron RM, Maron BA, Philp NJ, Hariri LP, Kim EY, Wei KS, Steinhauser ML, Knipe RS, Rutter J, Oldham WM (2026). Lactate transport inhibition therapeutically reprograms fibroblast metabolism in experimental pulmonary fibrosis. Sci Transl Med, 18(848), eads2673.
- Arellano NS, Heaton WL, Nauman MC, Runnels AE, Gomez-Villa J, Vanni D, Gaviria M, Fujita M, Krah NM, Ciboddo M, Yadav S, Brown CT, Bowden PD, Chen AK, Henning C, Catrical S, Casetti IC, Borsani O, Rumi E, Pietra D, Plo I, Marty C, Marchetti M, Patel AB, Saygin C, Elf SE (2025). Type 2 calreticulin mutations activate ATF6 to promote BCL-xL-mediated survival in myeloproliferative neoplasms. Blood, 146(8), 971-983.
- Ziehr DR, Li F, Parnell KM, Krah NM, Leahy KJ, Guillermier C, Varon J, Baron RM, Maron BA, Philp NJ, Hariri LP, Kim EY, Steinhauser ML, Knipe RS, Rutter J, Oldham WM (2024). Lactate transport inhibition therapeutically reprograms fibroblast metabolism in experimental pulmonary fibrosis. bioRxiv.
- Bensard CL, Wisidagama DR, Olson KA, Berg JA, Krah NM, Schell JC, Nowinski SM, Fogarty S, Bott AJ, Wei P, Dove KK, Tanner JM, Panic V, Cluntun A, Lettlova S, Earl CS, Namnath DF, Vzquez-Arregun K, Villanueva CJ, Tantin D, Murtaugh LC, Evason KJ, Ducker GS, Thummel CS, Rutter J (2019). Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier. Cell Metab, 31(2), 284-300.e7.
- Krah NM, Narayanan SM, Yugawa DE, Straley JA, Wright CVE, MacDonald RJ, Murtaugh LC (2019). Prevention and Reversion of Pancreatic Tumorigenesis through a Differentiation-Based Mechanism. Dev Cell, 50(6), 744-754.e4.
- Krah NM, Hersh AL (2019). OPAT for avoidance of hospitalisation in children. Lancet Infect Dis, 19(5), 450-451.
- Krah NM, Bardsley T, Nelson R, Esquibel L, Crosby M, Byington CL, Pavia AT, Hersh AL (2019). Economic Burden of Home Antimicrobial Therapy: OPAT Versus Oral Therapy. Hosp Pediatr, 9(4), 234-240.
- Krah NM, Olson J, Thorell EA, Esquibel L, Osguthorpe RJ, Pavia AT, Hersh AL (2017). Outpatient Parenteral Antimicrobial Therapy in Young Infants. J Pediatric Infect Dis Soc, 7(2), e40-e42.
- Tanner JM, Bensard C, Wei P, Krah NM, Schell JC, Gardiner J, Schiffman J, Lessnick SL, Rutter J (2017). EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma. Mol Cancer Res, 15(11), 1517-1530.
- Krah NM, De La O JP, Swift GH, Hoang CQ, Willet SG, Chen Pan F, Cash GM, Bronner MP, Wright CV, MacDonald RJ, Murtaugh LC (2015). The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma. Elife, 4.
- Stahl A, Joyal JS, Chen J, Sapieha P, Juan AM, Hatton CJ, Pei DT, Hurst CG, Seaward MR, Krah NM, Dennison RJ, Greene ER, Boscolo E, Panigrahy D, Smith LE (2012). SOCS3 is an endogenous inhibitor of pathologic angiogenesis. Blood, 120(14), 2925-9.
- Sapieha P, Chen J, Stahl A, Seaward MR, Favazza TL, Juan AM, Hatton CJ, Joyal JS, Krah NM, Dennison RJ, Tang J, Kern TS, Akula JD, Smith LE (2012). Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice. Nutr Diabetes, 2(7), e36.
- Chen J, Stahl A, Krah NM, Seaward MR, Joyal JS, Juan AM, Hatton CJ, Aderman CM, Dennison RJ, Willett KL, Sapieha P, Smith LE (2012). Retinal expression of Wnt-pathway mediated genes in low-density lipoprotein receptor-related protein 5 (Lrp5) knockout mice. PLoS One, 7(1), e30203.
- Chen J, Stahl A, Krah NM, Seaward MR, Dennison RJ, Sapieha P, Hua J, Hatton CJ, Juan AM, Aderman CM, Willett KL, Guerin KI, Mammoto A, Campbell M, Smith LE (2011). Wnt signaling mediates pathological vascular growth in proliferative retinopathy. Circulation, 124(17), 1871-81.
- Hua J, Guerin KI, Chen J, Michn S, Stahl A, Krah NM, Seaward MR, Dennison RJ, Juan AM, Hatton CJ, Sapieha P, Sinclair DA, Smith LE (2011). Resveratrol inhibits pathologic retinal neovascularization in Vldlr(-/-) mice. Invest Ophthalmol Vis Sci, 52(5), 2809-16.
- Sapieha P, Stahl A, Chen J, Seaward MR, Willett KL, Krah NM, Dennison RJ, Connor KM, Aderman CM, Liclican E, Carughi A, Perelman D, Kanaoka Y, Sangiovanni JP, Gronert K, Smith LE (2011). 5-Lipoxygenase metabolite 4-HDHA is a mediator of the antiangiogenic effect of ω-3 polyunsaturated fatty acids. Sci Transl Med, 3(69), 69ra12.
- Stahl A, Chen J, Sapieha P, Seaward MR, Krah NM, Dennison RJ, Favazza T, Bucher F, Lfqvist C, Ong H, Hellstrm A, Chemtob S, Akula JD, Smith LE (2010). Postnatal weight gain modifies severity and functional outcome of oxygen-induced proliferative retinopathy. Am J Pathol, 177(6), 2715-23.
- Stahl A, Sapieha P, Connor KM, Sangiovanni JP, Chen J, Aderman CM, Willett KL, Krah NM, Dennison RJ, Seaward MR, Guerin KI, Hua J, Smith LE (2010). Short communication: PPAR gamma mediates a direct antiangiogenic effect of omega 3-PUFAs in proliferative retinopathy. Circ Res, 107(4), 495-500.
- Krah NM, Logan BA (2010). Loss of psbS expression reduces vegetative growth, reproductive output, and light-limited, but not light-saturated, photosynthesis in Arabidopsis thaliana (Brassicaceae) grown in temperate light environments. Am J Bot, 97(4), 644-9.
- Stahl A, Connor KM, Sapieha P, Willett KL, Krah NM, Dennison RJ, Chen J, Guerin KI, Smith LE (2009). Computer-aided quantification of retinal neovascularization. Angiogenesis, 12(3), 297-301.
- Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, Guerin KI, Sapieha P, Stahl A, Willett KL, Smith LE (2009). Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc, 4(11), 1565-73.
Review
- Krah NM, Fai C, Sutton KN, Rader A, Barton KD, Skalla LA, Boucher HW, Collyar D, Miller J, Oakes M, Ruffin F, Wang TW, King HA, Doernberg SB (2026). A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia. [Review]. Clin Infect Dis, 81(Supplement_1), S32-S39.
- Krah NM, Jones TW, Lake J, Hersh AL (2020). The impact of antibiotic allergy labels on antibiotic exposure, clinical outcomes, and healthcare costs: A systematic review. [Review]. Infect Control Hosp Epidemiol, 42(5), 530-548.
- Krah NM, Murtaugh LC (2017). Differentiation and Inflammation: 'Best Enemies' in Gastrointestinal Carcinogenesis. [Review]. Trends Cancer, 2(12), 723-735.
- Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, Krah NM, Seaward MR, Willett KL, Aderman CM, Guerin KI, Hua J, Lfqvist C, Hellstrm A, Smith LE (2010). The mouse retina as an angiogenesis model. [Review]. Invest Ophthalmol Vis Sci, 51(6), 2813-26.
Case Report
- Krah NM, Hoeg R, Shami PJ, Elf SE, Lee LE, Pemmaraju N, Patel AB (2025). Real-world management of blastic plasmacytoid dendritic cell neoplasm at an academic center with a broad regional referral base. Leuk Res Rep, 24, 100541.
- Krah NM, Miotke L, Li P, Patel JL, Bowen AR, Pomicter AD, Patel AB (2023). JAK2 R683S Mutation Resulting in Dual Diagnoses of Chronic Eosinophilic Leukemia and Myelodysplastic/Myeloproliferative Overlap Syndrome. J Natl Compr Canc Netw, 21(12), 1218-1223.